DAEWOONG PHARMACEUTICAL
Daewoong Pharmaceutical Co., Ltd. has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company by 2020.
DAEWOONG PHARMACEUTICAL
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
1945-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Medico Intercontinental Limited
Medico Intercontinental Limited is a health care based company that aims at developing human health through pursuits in science & therapies.
Mochida Pharmaceutical
Mochida Pharmaceutical is a healthcare company provides pharmaceuticals, healthcare products, and medical equipment businesses.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-04-11 | Turn.bio | Daewoong Pharmaceutical investment in Venture Round - Turn.bio | N/A |
2021-08-19 | Alloplex Biotherapeutics | Daewoong Pharmaceutical investment in Corporate Round - Alloplex Biotherapeutics | 1000 K USD |
More informations about "Daewoong Pharmaceutical"
Daewoong Pharmaโs Open Collaboration - ๋์ ์ ์ฝ
Daewoong Pharma is engaged in research to contribute to humanity through the development of innovative medicines. Daewoong Pharma is striving to develop innovative drugs that can improve global health.See details»
DAEWOONG PHARMACEUTICAL 2023 SUSTAINABILITY REPORT
Coming into 2023, Daewoong Pharmaceutical has established its ESG strategy of โCARE for people and planetโ for a sustainable future and pledged to fulfill it. The publication of this . โฆSee details»
Daewoong Pharmaceutical - LinkedIn
Establish in 1945, Daewoong Pharmaceuticals Co., Ltd. is a public South Korean pharmaceutical company that develops, manufactures, and commercializes pharmaceuticals for both domestic and international markets.See details»
Daewoong Pharmaceutical - Crunchbase Investor Profile
Daewoong Pharmaceutical is a healthcare company that provides pharmaceuticals solutions and services for consumers. Daewoong Pharmaceutical announced its 2023 financial results, โฆSee details»
Daewoong Pharmaceutical - LinkedIn
Establish in 1945, Daewoong Pharmaceuticals Co., Ltd. is a public South Korean pharmaceutical company that develops, manufactures, and commercializes pharmaceuticals for both domestic โฆSee details»
Daewoong Pharmaceutical Company - PitchBook
Dec 31, 2021 Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It โฆSee details»
Daewoong Pharmaceutical - The Org
Establish in 1945, Daewoong Pharmaceuticals Co., Ltd. is a public South Korean pharmaceutical company that develops, manufactures, and commercializes pharmaceuticals for both domestic โฆSee details»
Daewoong Pharmaceutical Co., Ltd. - Drug pipelines, Patents
May 1, 2023 MILAN, Oct. 9, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae Lee) announced on the 9th that they will present their cutting โฆSee details»
Daewoong Pharmaceutical Company Profile - Craft
Oct 11, 2024 Daewoong Pharmaceutical is a healthcare company that provides pharmaceutical solutions and services. It offers products in therapeutic areas, such as endocrinology, central โฆSee details»
Daewoong Pharmaceutical - Products, Competitors, Financials, โฆ
Daewoong Pharmaceutical is a global healthcare group focused on pharmaceuticals and services that contribute to improving the quality of life.See details»
Daewoong Pharmaceutical - Overview, News & Similar companies
Feb 1, 2021 Daewoong Pharmaceutical has announced that its subsidiary formed with Avacta Group, AffyXell Therapeutics, secured $7.3 million in Series A funding.See details»
Daewoong Pharmaceutical | Company Overview & News - Forbes
Daewoong Pharmaceutical Company Stats. As of October 2020. Industry Drugs & Biotechnology Founded 1945 Headquarters Seoul CEO & President Seng-Ho Jeon. Forbes Lists #298. โฆSee details»
Shawn Park - AEON Biopharma
Park has been a director at Daewoong since March 2023 and was a director at Daewoong Co., Ltd., an affiliate of Daewoong, from March 2021 to March 2023. In addition, Mr. Park is โฆSee details»
Daewoong Pharmaceutical | JMP
By harnessing large quantities of data and implementing JMP ® to analyze them more effectively, Daewoong can increase the quality of its products and satisfy diverse regulatory requirements, โฆSee details»
[Herald Interview] Daewoong Pharmaceutical steps onto global โฆ
Jul 12, 2023 Koreaโs leading pharmaceutical firm Daewoong Pharmaceutical aims to achieve a fivefold increase in overseas sales within the next five years through the introduction of new โฆSee details»
Daewoong Pharmaceutical's Bersiporocin Receives 'Orphan Drug ...
Jan 29, 2024 Daewoong Pharmaceutical's Bersiporocin (DWN12088) has been recognized as a significant advancement in treating idiopathic pulmonary fibrosis (IPF), a rare and debilitating โฆSee details»
Daewoong Pharmaceuticals Company Profile - Office Locations
Daewoong Pharmaceuticals has 5 employees across 12 locations. See insights on Daewoong Pharmaceuticals including office locations, competitors, revenue, financials, executives, โฆSee details»
Daewoong sets $745 million sales target for duo of new drugs
Oct 26, 2023 BARCELONA, Spain โ Daewoong Pharmaceutical, Koreaโs fourth-largest pharmaceutical company in terms of revenue, hopes to achieve $745 million in global sales โฆSee details»
Daewoong Pharmaceutical Captivates Global Experts at AMWC โฆ
3 days ago Daewoong Pharmaceutical (CEO Seong-su Park, Chang-jae Lee) announced on December 5 that it participated in the Aesthetic & Anti-Aging Medicine World Congress in โฆSee details»